vimarsana.com
Home
Live Updates
Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research : comparemela.com
Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research
Brings extensive experience in all phases of oncology drug developmentHANOVER, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals,...
Related Keywords
San Diego ,
California ,
United States ,
Stanford University ,
Patrick Lin ,
Processa Ngcs ,
Lyvonne Briggs ,
Steven Cha ,
Stanford University School Of Medicine ,
Nasdaq ,
Processa Team ,
Company Contact ,
Pharmaceuticals Inc ,
Pfizer ,
Clinical Research ,
Processa Pharmaceuticals Inc ,
Processa Pharmaceuticals ,
Tufts University School Of Medicine ,
University Of California ,
Senior Vice President ,
Chief Executive Officer ,
Cap Phase ,
Puma Biotechnology ,
Stanford University School ,
Cell Biology ,
Medical Degree ,
Tufts University School ,
Processa Regulatory Science Approach ,
Optimal Dosage Regimens ,
Regulatory Science Approach ,
Optimal Dosage Regimen ,
Optimus Oncology ,
Next Generation Capecitabine ,
Next Generation Gemcitabine ,
Next Generation Irinotecan ,
Relations Contact ,
comparemela.com © 2020. All Rights Reserved.